Results 161 to 170 of about 2,350,568 (218)

Carcinogenic Risk of Bath PUVA in Comparison to Oral PUVA Therapy

Dermatology, 1999
The potential carcinogenic risk of bath PUVA therapy was compared to that of systemic (oral) PUVA. An analysis of the epidemiological data on cancer risk following bath PUVA with trimethylpsoralen does not support the conclusion that bath PUVA per se is less carcinogenic than systemic PUVA with 8-methoxypsoralen (8-MOP).
Shephard SE, Panizzon RG
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

PUVA therapy and the lens reconsidered

Documenta Ophthalmologica, 1988
On the basis of animal experiments there appears to be a theoretical chance that lens changes will occur in patients receiving PUVA treatment. In the published studies the incidence of lens changes in patients treated with PUVA is very low. In this study changes were observed both during PUVA treatment and during a long follow-up period. The absence of
W L, Van Deenen, W P, Lamers
exaly   +3 more sources

Successful Treatment of Scleroderma with PUVA Therapy

Journal of Dermatology, 1996
AbstractPUVA therapy was carried out on four patients with scleroderma; three of them had cutaneous manifestations of progressive systemic sclerosis and one other exhibited generalized morphea. PUVA therapy was given with daily doses of 0.25 J/cm2 or 0.4 J/cm2 for 3–8 weeks, resulting in total doses between 3.5 J/cm2 and 9.6 J/cm2.
Takuro Kanekura
exaly   +3 more sources

PUVA THERAPY OF CHRONIC ACTINIC DERMATITIS

Australasian Journal of Dermatology, 1988
SummaryA modified PUVA regime was used to treat five men with long‐standing chronic actinic dermatitis. They are all now symptom free on monthly maintenance PUVA therapy and no longer react abnormally to ultra‐violet radiation, with consequent improvement of their quality of life.
S E, Sinclair, C, Hindson
exaly   +3 more sources

Hypertrichosis: A side-effect of PUVA therapy

Archives of Dermatological Research, 1985
L'hypertrichose est d'observation plus ou moins reguliere chez les patients traites par la PUVA ...
exaly   +3 more sources

PUVA therapy in lichen aureus

Journal of the American Academy of Dermatology, 2001
Lichen aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of lichen aureus that responded dramatically to photochemotherapy (PUVA).
T C, Ling, V, Goulden, M J, Goodfield
openaire   +2 more sources

Melanonychia associated with PUVA therapy

Journal of the American Academy of Dermatology, 2003
We describe a case of melanonychia induced by PUVA. This phenomenon likely is more common than the few reports in the literature indicate.
Leslie S, Ledbetter, Sylvia, Hsu
openaire   +2 more sources

OCULAR COMPLICATIONS OF PUVA THERAPY

Australasian Journal of Dermatology, 1993
SummaryPUVA, the combination of psoralen and long wave ultraviolet radiation is widely used in the management of psoriasis, vitiligo and several other dermatological disorders. The potential for long term treatment to cause ocular damage remains to be determined and despite the large numbers of patients who have received PUVA treatment, development of ...
J A, See, P, Weller
openaire   +2 more sources

An Evaluation of PUVA-Therapy for Alopecia areata

Dermatologica, 2009
30 patients with alopecia areata were treated with 8-methoxypsoralen orally combined with whole body UVA exposure. 9 patients showed more than 60% regrowth of hair, 8 of them had recurrences of hair loss within a mean time of 7.7 months. No selecting criteria could be found prophesying good results of PUVA therapy.
van der Schaar, W. W., Sillevis Smith, J. H.   +1 more
openaire   +3 more sources

Dose Measurement in PUVA Therapy

Dermatologica, 2009
The dose emitted by the fluorescent tubes used in PUVA therapy is not constant: it varies in function of time, age of the lamps, and several other factors. Exact knowledge of the dose given to the patient requires continuous measurement and integration of the UV-A output.
openaire   +2 more sources